TC Biopharm (Holdings) Plc TCBPW
Set alert
0.01 USD 0.00 0.00%
At close · Mar 21
0.006 Day range 0.0095
0.0149 52-week range 0.0151
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0095
- Prev close
- 0.006
- Mkt cap
- 1.28K
- Vol
- 452.61K
- Avg vol
- 0
- EPS
- -0.754
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.006
- High
- 0.0095
- Forward P/E
- 0.00
- Beta
- 0.25
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.754
- Beta
- 0.25
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -6.85M
- Total cash
- 980.96K
- Total debt
- 1.73M
- Return on equity
- -1217.48%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About TC Biopharm (Holdings) Plc
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- Website
- tcbiopharm.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on TCBPW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kepos Capital Lp | 6.25% | 470,588 | 7.06K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 3.12% | 235,294 | 3.53K | Sep 29, 2024 |
| Csenge Advisory Group | 0.25% | 18,862 | 282 | Sep 29, 2024 |
| Altium Capital Management, LP | 0.25% | 18,823 | 282 | Sep 29, 2024 |
| UBS Group AG | 0.02% | 1,181 | 17 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 71 | 1 | Sep 29, 2024 |